Mature B-Cell Non-Hodgkin Lymphoma
Information
- Disease name
- Mature B-Cell Non-Hodgkin Lymphoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02405676 | Active, not recruiting | Phase 2/Phase 3 | BNHL-2015 for Children or Adolescents in China | January 2015 | December 2024 |
| NCT03206671 | Recruiting | Phase 3 | Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents | August 3, 2017 | August 2024 |
| NCT04986865 | Recruiting | Phase 1 | A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas | December 15, 2021 | January 1, 2026 |
| NCT05490043 | Recruiting | Phase 1 | A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas | January 30, 2022 | December 30, 2024 |
| NCT05533775 | Recruiting | Phase 1/Phase 2 | A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma | November 16, 2022 | October 15, 2027 |